Invention Grant
- Patent Title: Thermostable Cas9 nucleases
-
Application No.: US15735359Application Date: 2016-06-06
-
Publication No.: US10689632B2Publication Date: 2020-06-23
- Inventor: John Van Der Oost , Martinus Johannes Arnoldus Daas , Servatius Wilhelmus Maria Kengen , Willem Meindert De Vos
- Applicant: Purac Biochem B.V.
- Applicant Address: NL Gorinchem
- Assignee: Purac Biochem B.V.
- Current Assignee: Purac Biochem B.V.
- Current Assignee Address: NL Gorinchem
- Agency: Riverside Law LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@212a7b75
- International Application: PCT/EP2016/062817 WO 20160606
- International Announcement: WO2016/198361 WO 20161215
- Main IPC: C12N15/63
- IPC: C12N15/63 ; C12N15/79 ; C12N15/85 ; C12N9/00 ; C12N9/22

Abstract:
The present invention relates to the field of genetic engineering and more particularly to nucleic acid editing and genome modification. The present invention provides an isolated Cas protein or polypeptide fragment thereof having an amino acid sequence of SEQ ID NO: 1 or a sequence of at least 77% identity therewith, wherein the Cas protein or polypeptide is capable of DNA cleavage at a temperature in the range 50° C. and 100° C. inclusive. The invention further provides isolated nucleic acid molecules encoding said Cas9 nucleases, expression vectors and host cells. The Cas9 nucleases disclosed herein provide novel tools for genetic engineering at elevated temperatures and are of particular value in the genetic manipulation of thermophilic organisms; particularly microorganisms.
Public/Granted literature
- US10731142B2 Thermostable Cas9 nucleases Public/Granted day:2020-08-04
Information query
IPC分类: